IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 40 filers reported holding IBERE PHARMACEUTICALS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16 | -99.9% | 141,843 | 0.0% | 0.00% | – |
| Q3 2022 | $21,000 | -62.5% | 141,843 | -50.0% | 0.00% | – |
| Q2 2022 | $56,000 | +36.6% | 283,686 | +100.0% | 0.00% | – |
| Q1 2022 | $41,000 | -47.4% | 141,843 | 0.0% | 0.00% | – |
| Q4 2021 | $78,000 | -6.0% | 141,843 | 0.0% | 0.00% | – |
| Q3 2021 | $83,000 | -13.5% | 141,843 | 0.0% | 0.00% | – |
| Q2 2021 | $96,000 | – | 141,843 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |